Atria Wealth Solutions, Inc. Intellia Therapeutics, Inc. Transaction History

Atria Wealth Solutions, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 22, 2023	BUY	$33.3 - $44.82 $241,458 - $324,989	7,251 New	7,251 $270,000
Q1 2023 Jun 14, 2023	BUY	$33.3 - $44.82 $18,714 - $25,188	562 Added 7.75%	7,813 $291,000
Q1 2023 May 10, 2023	SELL	$33.3 - $44.82 $18,714 - $25,188	-562 Reduced 7.19%	7,251 $270,000
Q4 2022 Aug 30, 2023	BUY	$33.21 - $62.69 $259,469 - $489,796	7,813 New	7,813 $272,000
Q4 2022 Feb 13, 2023	SELL	$33.21 - $62.69 $4,981 - $9,403	-150 Reduced 1.88%	7,813 $272,000
Q3 2022 Nov 14, 2022	SELL	$53.92 - $71.7 $17,955 - $23,876	-333 Reduced 4.01%	7,963 $446,000
Q2 2022 Aug 15, 2022	BUY	$38.49 - $76.21 $151,881 - $300,724	3,946 Added 90.71%	8,296 $429,000
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $253,474 - $517,606	4,350 New	4,350 $316,000

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.